Ansell Limited (ANSLY)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ansell Limited (ANSLY) with AI Score 56/100 (Hold). Ansell Limited is a global leader in protection solutions, specializing in healthcare and industrial safety products. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 15, 2026Ansell Limited (ANSLY) Healthcare & Pipeline Overview
Ansell Limited stands as a prominent provider of protective solutions in the healthcare and industrial sectors, leveraging over a century of expertise to deliver high-quality gloves and protective clothing across global markets.
Investment Thesis
Ansell Limited's investment thesis is underpinned by its strong market position and robust financial metrics, including a market capitalization of $3.04 billion and a P/E ratio of 21.54. The company's diverse product portfolio in the Healthcare and Industrial segments positions it well to capitalize on growing demand for protective solutions, particularly in the wake of increased health and safety regulations globally. Ansell's gross margin of 41.9% and profit margin of 6.7% reflect its operational efficiency and ability to maintain profitability amid competitive pressures. Key growth catalysts include the expansion of its product lines, strategic acquisitions, and increasing penetration in emerging markets. However, investors should be mindful of potential risks, including regulatory challenges and market competition. Overall, Ansell's established brand, commitment to innovation, and strategic focus on high-growth areas provide a solid foundation for future growth.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $3.04B reflects strong investor confidence in Ansell's growth potential.
- P/E ratio of 21.54 indicates favorable valuation relative to earnings.
- Profit margin of 6.7% showcases operational efficiency in a competitive market.
- Gross margin of 41.9% exceeds industry averages, highlighting product value.
- Dividend yield of 2.72% provides a steady income stream for investors.
Competitors & Peers
Strengths
- Established brand with over 120 years of industry experience.
- Diverse product offerings across healthcare and industrial segments.
- Strong operational efficiency reflected in high gross margins.
- Global presence with a well-established distribution network.
Weaknesses
- Dependence on regulatory approvals for product sales.
- Exposure to fluctuations in raw material costs.
- Potential vulnerability to market competition and pricing pressures.
Catalysts
- Expansion of product lines in response to growing healthcare demands.
- Strategic partnerships with key players in healthcare and industrial sectors.
- Continuous investment in research and development to drive innovation.
Risks
- Regulatory challenges impacting product approvals and market access.
- Fluctuations in raw material costs affecting profit margins.
- Intense competition from both established and emerging companies.
Growth Opportunities
- Growth opportunity 1: Ansell is poised to capitalize on the increasing demand for healthcare protective equipment, particularly surgical and examination gloves, which are projected to grow at a CAGR of 7% through 2028. This growth is driven by heightened awareness of hygiene and safety in medical environments, positioning Ansell as a key supplier to hospitals and healthcare facilities globally.
- Growth opportunity 2: The industrial protective clothing market is expected to reach $10 billion by 2027, with Ansell's innovative chemical protective solutions playing a crucial role. As industries prioritize worker safety and compliance with regulations, Ansell's established reputation and diverse product range will enable it to capture a larger share of this expanding market.
- Growth opportunity 3: Ansell's strategic focus on emerging markets presents significant growth potential, particularly in regions like Asia-Pacific and Latin America, where industrialization and healthcare investments are on the rise. By leveraging its global distribution network and local partnerships, Ansell aims to enhance its market presence in these high-growth areas over the next five years.
- Growth opportunity 4: The ongoing trend towards sustainability and eco-friendly products is creating opportunities for Ansell to innovate and develop biodegradable and recyclable protective solutions. This aligns with global consumer preferences and regulatory trends, potentially increasing market share and brand loyalty among environmentally conscious customers.
- Growth opportunity 5: Ansell's commitment to research and development is expected to drive innovation in product offerings, particularly in advanced materials and smart textiles. By investing in cutting-edge technology, Ansell can differentiate itself from competitors and address evolving customer needs, fostering long-term growth.
Opportunities
- Growing demand for healthcare protective equipment post-pandemic.
- Expansion into emerging markets with increasing healthcare investments.
- Innovation in sustainable and eco-friendly product lines.
Threats
- Intense competition from established and emerging players.
- Regulatory challenges and compliance risks in various markets.
- Economic downturns affecting industrial demand for protective solutions.
Competitive Advantages
- Strong brand recognition and reputation built over more than a century.
- Diverse product portfolio catering to multiple industries and customer segments.
- Established global distribution network enhancing market reach.
- Commitment to innovation and quality, leading to high customer loyalty.
- Strategic partnerships with key players in healthcare and industrial sectors.
About ANSLY
Founded in 1893, Ansell Limited has evolved from its origins as Pacific Dunlop Limited to become a leading global provider of protection solutions. Headquartered in Richmond, Australia, Ansell operates across several geographic regions, including the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. The company is divided into two main segments: Healthcare and Industrial. The Healthcare segment focuses on manufacturing and marketing a wide range of products, including surgical gloves, examination gloves, and sterile garments, catering to various sectors such as hospitals, dental practices, and life sciences. In contrast, the Industrial segment produces hand and chemical protective clothing for diverse applications, including automotive, food, construction, and oil and gas industries. Ansell's commitment to innovation and quality has established it as a trusted partner for healthcare professionals and industrial workers alike, positioning the company favorably in a competitive landscape. With a workforce of approximately 15,000 employees, Ansell continues to expand its product offerings and geographic reach, ensuring that it meets the evolving needs of its customers worldwide.
What They Do
- Design and manufacture protective solutions for healthcare and industrial applications.
- Offer a wide range of surgical and examination gloves for medical use.
- Produce chemical protective clothing for various industrial sectors.
- Develop and market safety solutions for first responders and emergency services.
- Provide consumables for laboratories and life sciences companies.
- Focus on innovation and quality to meet diverse customer needs.
Business Model
- Generate revenue through the sale of protective gloves and clothing across healthcare and industrial sectors.
- Leverage a global distribution network to reach diverse markets.
- Invest in research and development to enhance product offerings and maintain competitive advantage.
- Form strategic partnerships and collaborations to expand market presence.
- Implement sustainability initiatives to align with customer preferences and regulatory requirements.
Industry Context
The medical instruments and supplies industry is experiencing significant growth, driven by increasing awareness of health and safety standards and the rising demand for protective equipment. Ansell Limited is well-positioned within this industry, leveraging its extensive experience and innovative product offerings to capture market share. The global market for personal protective equipment (PPE) is projected to grow substantially, fueled by ongoing health crises and regulatory requirements across various sectors. Ansell faces competition from companies such as GLPGF, HYPMY, MAHLY, MEPDF, and RGEDF, each vying for dominance in this expanding market.
Key Customers
- Healthcare providers, including hospitals and surgical centers.
- Dental practices and veterinary clinics requiring protective solutions.
- Industrial companies in sectors such as automotive, construction, and oil and gas.
- Laboratories and life sciences organizations seeking specialized consumables.
- First responders and emergency services needing reliable protective gear.
Financials
Chart & Info
Ansell Limited (ANSLY) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ANSLY.
Price Targets
Wall Street price target analysis for ANSLY.
MoonshotScore
What does this score mean?
The MoonshotScore rates ANSLY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Nathalie Ahlstrom
CEO
Nathalie Ahlstrom has a distinguished career in the healthcare and industrial sectors, holding various leadership roles in multinational companies. She holds a degree in Business Administration and has extensive experience in operational management, strategic planning, and market development. Prior to joining Ansell, she served as a senior executive at several leading firms, focusing on driving growth and innovation.
Track Record: Under Nathalie Ahlstrom's leadership, Ansell has successfully expanded its product portfolio and entered new markets, achieving significant revenue growth. Her strategic vision has led to enhanced operational efficiencies and a strengthened brand presence globally.
Ansell Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) represents shares of a foreign company traded on U.S. exchanges. ANSLY is classified as a Level 1 ADR, allowing it to trade on the OTC market without being subject to the same regulatory requirements as U.S. companies.
- Home Market Ticker: ANSL trades on the Australian Securities Exchange (ASX).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: ANSL
ANSLY OTC Market Information
The OTC Other tier includes securities that do not meet the requirements for higher tiers like OTCQX or OTCQB. These stocks may have less stringent reporting requirements and are generally considered less liquid than those on major exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower liquidity may result in higher volatility and difficulty executing trades.
- Less stringent reporting requirements can lead to reduced transparency for investors.
- Potential for wider bid-ask spreads, impacting trading costs.
- Verify the company's financial reports and disclosures.
- Assess the competitive landscape and market position.
- Review recent news and developments affecting the company.
- Evaluate management's track record and strategic vision.
- Understand currency risks associated with investing in foreign stocks.
- Established history and reputation in the industry since 1893.
- Presence on the Australian Securities Exchange (ASX).
- Global operations and diverse product offerings enhancing credibility.
What Investors Ask About Ansell Limited (ANSLY) — Healthcare
What does Ansell Limited do?
Ansell Limited specializes in designing, developing, and manufacturing protective solutions for healthcare and industrial applications. The company offers a wide range of products, including surgical gloves, examination gloves, and protective clothing for various industries, ensuring safety and compliance for healthcare providers and industrial workers.
What do analysts say about ANSLY stock?
Analysts generally view ANSLY as a stable investment within the healthcare sector, emphasizing its strong market position and solid financial metrics. Key valuation metrics, including a P/E ratio of 21.54 and a profit margin of 6.7%, indicate a favorable outlook for growth, particularly as demand for protective solutions continues to rise.
What are the main risks for ANSLY?
Key risks for Ansell Limited include regulatory challenges that may affect product approvals and market access, fluctuations in raw material costs that can impact profit margins, and ongoing competition from both established and emerging players in the protective solutions market. Investors may want to evaluate these factors when evaluating the company's future performance.
What are the key factors to evaluate for ANSLY?
Ansell Limited (ANSLY) currently holds an AI score of 56/100, indicating moderate score. Key strength: Established brand with over 120 years of industry experience. Primary risk to monitor: Regulatory challenges impacting product approvals and market access. This is not financial advice.
How frequently does ANSLY data refresh on this page?
ANSLY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ANSLY's recent stock price performance?
Recent price movement in Ansell Limited (ANSLY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brand with over 120 years of industry experience. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ANSLY overvalued or undervalued right now?
Determining whether Ansell Limited (ANSLY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ANSLY?
Before investing in Ansell Limited (ANSLY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is sourced from reliable industry reports and company disclosures.